OCCUPATIONAL RISK OF HEPATITIS-B AND HEPATITIS-C INFECTIONS IN SAUDI MEDICAL STAFF

被引:14
作者
ALSOHAIBANI, MO
ALSHEIKH, EH
ALBALLAL, SJ
MIRGHANI, MAM
RAMIA, S
机构
[1] KING FAISAL UNIV, DEPT PATHOL, AL KHOBAR, SAUDI ARABIA
[2] KING FAISAL UNIV, DEPT COMMUNITY & FAMILY MED, AL KHOBAR, SAUDI ARABIA
关键词
HEPATITIS B VIRUS MARKERS; HEPATITIS C VIRUS MARKERS; MEDICAL STUDENTS; MEDICAL STAFF; SAUDI ARABIA;
D O I
10.1016/0195-6701(95)90169-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of markers for hepatitis B virus (HBV) and hepatitis C virus (HCV) was studied among final year medical students and the medical staff at two university teaching hospitals in Saudi Arabia. At King Khalid University Hospital (KKUH) in Riyadh, evidence of exposure to HBV in the male medical staff (42.9%) was significantly greater than among medical students (25.3% males, 19.3% females; P=0.0041) or the controls (28.6% males, 17.1% females; P=0.0095). At King Fahad University Hospital (KFUH) in Al-Khobar, although the prevalence of exposure in the medical staff (28.3%) was higher than that in the controls (18.5%) the difference was not statistically significant (P>0.05) and this could be due to the small numbers tested (46 physicians, 54 controls). Regarding exposure to HCV there was no significant difference in markers of the virus among the three categories investigated (3.7% in the controls, 2.6% in medical students and 1.9% in the medical staff). The low risk of transmission in the medical staff could be due to the small amount of the virus in the blood of HCV carriers. It can be concluded from the study that, in contrast to HCV, the occupational risk of HBV infection is high among Saudi physicians and hence HBV vaccination to unexposed medical staff is the only way for effective prevention of infection.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 19 条
[1]  
AHTONE J, 1980, LANCET, V1, P1142
[2]   PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS AMONG SAUDI-ARABIAN CHILDREN - A COMMUNITY-BASED STUDY [J].
ALFALEH, FZ ;
AYOOLA, EA ;
ALJEFFRY, M ;
ALRASHED, R ;
ALMOFARREH, M ;
ARIF, M ;
RAMIA, S ;
ALKARAWI, M ;
ALSHABRAWY, M .
HEPATOLOGY, 1991, 14 (02) :215-218
[3]   INTEGRATION OF HEPATITIS-B VACCINE INTO THE EXPANDED PROGRAM ON IMMUNIZATION - THE SAUDI-ARABIAN EXPERIENCE [J].
ALFALEH, FZ ;
AYOOLA, EA ;
ALJEFFRY, M ;
ARIF, M ;
ALRASHED, RS ;
RAMIA, S .
ANNALS OF SAUDI MEDICINE, 1993, 13 (03) :231-236
[4]   SEROEPIDEMIOLOGY OF HEPATITIS-B VIRUS-INFECTION IN SAUDI-ARABIAN CHILDREN - A BASE-LINE SURVEY FOR MASS VACCINATION AGAINST HEPATITIS-B [J].
ALFALEH, FZ ;
AYOOLA, EA ;
ARIF, M ;
RAMIA, S ;
ALRASHED, R ;
ALJEFFRY, M ;
ALMOFARREH, M ;
ALKARAWI, M ;
ALSHABRAWY, M .
JOURNAL OF INFECTION, 1992, 24 (02) :197-206
[5]   HEPATITIS-C VIRUS-ANTIBODIES IN HIGH-RISK SAUDI GROUPS [J].
BAHAKIM, H ;
BAKIR, TMF ;
ARIF, M ;
RAMIA, S .
VOX SANGUINIS, 1991, 60 (03) :162-164
[6]   POSTTRANSFUSION NON-A, NON-B HEPATITIS IN CHIMPANZEES - PHYSICOCHEMICAL EVIDENCE THAT THE TUBULE-FORMING AGENT IS A SMALL, ENVELOPED VIRUS [J].
BRADLEY, DW ;
MCCAUSTLAND, KA ;
COOK, EH ;
SCHABLE, CA ;
EBERT, JW ;
MAYNARD, JE .
GASTROENTEROLOGY, 1985, 88 (03) :773-779
[7]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[8]  
ESTEBAN JI, 1989, LANCET, V2, P294
[9]  
FATHALLA SE, 1985, SAUDI MED J, V6, P236
[10]   OCCUPATIONAL RISK OF HEPATITIS-B INFECTION IN HOSPITAL WORKERS [J].
HADLER, SC ;
DOTO, IL ;
MAYNARD, JE ;
SMITH, J ;
CLARK, B ;
MOSLEY, J ;
EICKHOFF, T ;
HIMMELSBACH, CK ;
COLE, WR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1985, 6 (01) :24-31